This article first appeared on GuruFocus. Oxford Nanopore Technologies PLC (LSE:ONT) is set to release its Q4 2025 earnings on Mar 2, 2026. The consensus estimate for Q4 2025 revenue is $0.00, and the ...
OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...
Since the announcement, Bio-Techne’s shares have dipped 0.9%, closing at $61.19 in yesterday’s session. Asuragen brand is well known for its designed, high-quality molecular diagnostic products. The ...
Good morning, and welcome to our 2024 Half Year Interim Results Presentation. I'm Gordon Sanghera, Chief Executive of Oxford Nanopore, and I'm joined today by our CFO, Nick Keher. Today, we will talk ...
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. It also develops instruments like GridIONTM and MinIONTM which are adaptable ...
Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results